Increased GDF9 and BMP15 mRNA levels in cumulus granulosa cells correlate with oocyte maturation, fertilization, and embryo quality in humans by unknown
Li et al. Reproductive Biology and Endocrinology 2014, 12:81
http://www.rbej.com/content/12/1/81RESEARCH Open AccessIncreased GDF9 and BMP15 mRNA levels in
cumulus granulosa cells correlate with oocyte
maturation, fertilization, and embryo quality in
humans
Yi Li1, Rui-Qi Li1, Song-Bang Ou1, Ning-Feng Zhang1, Ling Ren2, Li-Na Wei3*, Qing-Xue Zhang1 and Dong-Zi Yang1Abstract
Background: Oocyte secreted factors (OSFs), including growth differentiation factor 9 (GDF9) and bone morphogenetic
protein 15 (BMP15), play an important role in the process of follicular development and oocyte maturation. Since OSFs
are expressed in oocytes and cumulus granulosa cells, the aim of the present study was to explore whether the
expression levels of GDF9 and BMP15 mRNAs in cumulus granulosa cells can be used as molecular markers for
predicting oocyte developmental potential.
Methods: Cumulus cells of 2426 cumulus-oocyte complexes were collected from 196 female patients who underwent
intracytoplasmic sperm injection (ICSI) and were used for mRNA detection on the egg retrieval day. Pearson correlation
analysis was used to analyze the correlation between OSF expression and general physiological parameters. Partial
correlation analysis was used to analyze the correlation between OSF expression and oocyte developmental potential.
Covariance analysis was used to compare OSF expression among different groups. Receiver operating characteristic
curves were used to examine the diagnostic value of GDF9 and BMP15 mRNA for predicting pregnancy.
Results: The expression levels of GDF9 and BMP15 mRNAs were significantly associated with age, body mass index
(BMI), oocyte maturation, normal fertilization, and cleavage rate (P < 0.05). The expression levels of GDF9 and BMP15
mRNAs in the group with high-quality embryos were significantly higher than those in the group without high-quality
embryos (P < 0.05). The expression levels of GDF9 and BMP15 mRNAs in the pregnancy group were significantly higher
than those in the nonpregnancy group (P < 0.05). The cut-off value of GDF9 mRNA for predicting pregnancy was 4.82,
with a sensitivity of 82% and a specificity of 64%. The cut-off value of BMP15 mRNA for predicting pregnancy was 2.60,
with a sensitivity of 78% and a specificity of 52%.
Conclusions: The expression levels of GDF9 and BMP15 mRNAs were closely associated with oocyte maturation,
fertilization, embryo quality, and pregnancy outcome; therefore, GDF9 and BMP15 mRNAs in cumulus granulosa cells
may be considered as new molecular markers for predicting oocyte developmental potential.
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Table 1 General information for all the subjects
Variable Value
Cases 196
Number of COCs 2426
Age (years) 32.81 ± 5.16
BMI (kg/m2) 21.43 ± 3.20
Antral follicle count (both ovaries) 13.66 ± 6.82
Ovary volume (mL) 5.67 ± 3.02
FSH (IU/L) 8.86 ± 4.34
LH (IU/L) 5.18 ± 3.26
E2 (pg/mL) 56.29 ± 7.89
T (ng/L) 1.73 ± 0.92
PRL (pg/mL) 16.61 ± 10.01
Days of stimulation 10.83 ± 3.42
Gonadotropin dose (IU) 2157.83 ± 999.63
Retrieved oocytes 12.25 ± 7.93
Oocyte maturation rate (%) 83.76 ± 17.54
Normal fertilization rate (%) 70.49 ± 24.47
Cleavage rate (%) 86.67 ± 21.98
Pregnancy rate (%) 51.02
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The oocyte developmental potential is one of the key
factors for determining the successful rate of in vitro
fertilization and embryo transfer (IVF-ET). The accurate
evaluation of oocyte developmental potential is an im-
portant issue in assisted reproduction. The traditional
method uses morphological scoring. The advantages of
morphological scoring lie in its simplicity, convenience,
and fast speed [1-3]. However, the main shortcoming of
this method is that it depends too much on the abilities
of the technician, so it is difficult to reach a uniform
standard. In some cases, the morphological scoring may
not accurately reflect the oocyte developmental potential
and embryo quality [4].
Recently, global assessment strategies including genomic,
transcriptomic, and proteomic approaches have been
applied in assisted reproduction [5]. These strategies aim
to present a “molecular profile” of embryo development
by detecting the chemical components in the oocyte,
granulosa cells, follicular fluid, and embryo culture
medium. These methods pave a new way to enhance the
accuracy of the oocyte developmental potential.
Granulosa cells are distributed on the follicular wall
(mural granulosa cells) or closely adjacent to the oocyte
(cumulus granulosa cells). The physiological function
of mural granulosa cells is predominantly related to
hormone secretion. Cumulus granulosa cells often
exchange biological signals with oocytes through the
gap junction [6-8]. There is a mutual communication
between cumulus granulosa cells and the oocyte. Recent
studies have shown that the expression levels of some
genes in cumulus granulosa cells are helpful for predicting
the oocyte developmental potential, such as hyaluronic
acid synthase 2 (HAS2), gremlin 1 (GREM1), etc. [9,10].
Since cumulus granulosa cells are by-products of intracy-
toplasmic sperm injection (ICSI) and the method of
detecting gene expression in cumulus granulosa cells does
not affect the oocyte developmental potential, it is very
possible to screen suitable potential biomarkers for pre-
dicting oocyte developmental potential in IVF clinics.
Oocyte secreted factors (OSFs) include growth differen-
tiation factor 9 (GDF9) and bone morphogenetic protein
15 (BMP15). Both factors play an important role in the
process of follicular development from the recruitment of
the primordial follicle to ovulation and even in corpus
luteum formation [11-13]. OSFs contribute to promoting
the proliferation and differentiation of granulosa cells
and oocyte maturation through paracrine and autocrine
signaling pathways. Previous studies have indicated that
higher GDF9 and BMP15 levels in the follicular fluid
are significantly associated with oocyte maturation and
embryo quality [14-16]. In vitro studies have shown that
GDF9 and BMP15 may stimulate M-phase-promoting
factor (MPF) and mitogen-activated protein kinase (MAPK)activities in oocytes and improve oocyte quality and subse-
quent developmental potential [17,18]. In addition, it has
been confirmed by many studies that OSFs are expressed
both in oocytes and cumulus granulosa cells [19-21]. The
aims of the present study were to detect the expression
levels of GDF9 and BMP15 mRNAs in cumulus granulosa
cells and to analyze the correlation between their expres-
sion levels and the oocyte developmental potential.
Methods
Study design
This study was approved by the Institutional Review
Board of Sun Yat-Sen University in March 2012 (NO.
E2012003). All the subjects signed the informed consent.
This retrospective study was conducted at the Center for
Reproductive Medicine in Memorial Hospital of Sun
Yat-Sen University from September 2012 to April 2013.
In total, 196 women who underwent ICSI because
their husbands were diagnosed as having severe oligo-
spermia and asthenospermia (total number <1 × 106/ml,
motility <5%) were recruited into this study. The general
information of the patients is presented in Table 1. The
inclusion criteria for all patients included a long protocol
for ovarian stimulation, age ≤45 years, body mass index
(BMI) of 17–35 kg/m2, and basal follicle-stimulating
hormone (FSH) level ≤20 IU/L. The exclusion criteria
included a history of previous poor response, recurrent
implantation failure (failed to achieve a pregnancy after
three or more cycles), submucosal fibroids, intrauterine
adhesion, congenital uterine malformation, hydrosalpinx,
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ovarian syndrome.
Ovarian stimulation protocol
All subjects underwent a long protocol for ovarian
stimulation. The blood was taken for determining the
basal levels of endocrine hormones during the menstrual
cycle. Endocrine hormones such as FSH, luteinizing hor-
mone (LH), estradiol (E2), testosterone (T), and prolactin
(PRL) were measured by an Axsym chemiluminescence
detection system (Axsym; Abbott Laboratories, Rungis,
France). A gonadotropin-releasing hormone agonist
(1.25 mg, Ipsen Pharma Biotech, Paris, France) was
subcutaneously injected for pituitary down regulation.
Gonadotropin (Gonal-f, 150–300 IU; Merck Serono,
Darmstadt, Germany) was subcutaneously injected for
ovarian hyperstimulation 2 weeks after downregulation.
Human chorionic gonadotropin (hCG, 10,000 IU; Northern
Pharma Inc., Rostov-Na-Dony, Russia) was intramuscularly
injected when the diameter of at least three dominant
follicles was larger than 18 mm. The collection of
cumulus-oocyte complexes (COCs) was conducted withFigure 1 Pearson analysis was used to analyze the correlation betwee
patients who underwent ICSI. The numbers on the horizzontal-axes refer
refer to the relative mRNA expression of GDF9 or BMP15. (a) The correlatio
correlation between BMI and the relative expression of GDF9 mRNA. (c) Th
(d) The correlation between age and the relative expression of BMP15 mRN
BMP15 mRNA. (f) The correlation between FSH and the relative expressiona 17G needle under ultrasound monitoring 36 h after
hCG injection.
Quantitative polymerase chain reaction (qPCR)
In total, 2426 COCs retrieved from pooled follicles of
individual patients were cultured in vitro for 2 h; then,
the cumulus granulosa cells were stripped off with visual-
ization under an inverted micoscope after hyaluronidase
digestion. The stripped cumulus granulosa cells (1 × 102–
5 × 103) were rinsed with phosphate-buffered saline two
times and mixed with Trizol (Invitrogen, Grand Island,
NY, USA). Total RNA was extracted with Trizol and
reversely transcribed into cDNA with the Superscript
III kit (Invitrogen, Grand Island, NY, USA). The qPCR
was performed with Taqman fluorescent probes and an
ABI Prism7700 detection system. The primers for GDF9
(NM_005448), BMP15 (NM_005260), and GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) were as
follows: GDF9: forward 5′-GGCAAGGCCTCACAGAGG
TA-3′, reverse 5′-CGGTAAACCACAGTGGCTCTAAC-
3′; BMP15: forward 5′-CTGCTTTGCCTGGCTGTGT-3′,
reverse 5′-CAAGGCATAGCCCCAGATTC-3′; GAPDH:n GDF9 and BMP15 expression and general parameters in 196
to the age, BMI, and FSH. The numbers on the y longitudinal axes
n between age and the relative expression of GDF9 mRNA. (b) The
e correlation between FSH and the relative expression of GDF9 mRNA.
A. (e) The correlation between BMI and the relative expression of
of BMP15 mRNA.
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5′-CAGTCTTCTGGGTGGCAGTGA-3′. GAPDH was
used as the endogenous control for normalization. All the
PCR conditions consisted of 93°C for 3 min, followed by
40 cycles of 93°C for 45 s and 55°C for 1 min. The 2-ΔΔCt
algorithm was used to calculate the GDF9 and BMP15
mRNA levels relative to the GAPDH level.Oocyte and embryo assessment
Oocyte maturation was examined under an inverted
micoscope. If the first polar body was observed in the
oocyte cytoplasm, the oocyte was regarded as being at
the metaphase II (MII) stage. The oocyte maturation
rate refers to the number of MII oocytes divided by the
total number of all retrieved oocytes. The oocyte at the
MII stage was fertilized with the help of the ICSI pro-
cedure. Oocyte fertilization was observed 18–19 h after
ICSI. Normal fertilization was confirmed when two
pronuclei (2PN) were found in the cytoplasm. TheFigure 2 Partial correlation anlysis was used to analyze the correlatio
developmental potential in 196 patients who underwent ICSI. The num
normal fertilization rate (2PN), and cleavage rate. The numbers on the long
(a) The correlation between oocyte maturation rate and the relative expres
rate and the relative expression of GDF9 mRNA. (c) The correlation betwee
correlation between oocyte maturation rate and the relative expression of
the relative expression of BMP15 mRNA. (f) The correlation between cleavanormal fertilization rate refers to the number of fertil-
ized oocytes divided by the total number of all retrieved
oocytes. Embryo cleavage was examined 43–45 h after
ICSI. Normal embryo cleavage was defined when the
fertilized egg developed into an embryo with 4–6 blas-
tomeres. The cleavage rate refers to the number of
cleaved zygotes divided by the total number of all zy-
gotes. Embryo evaluation was conducted 67–69 h after
oocyte fertilization. A high-quality embryo should consist
of 7–9 blastomeres with a uniform size, and the fragment
proportion should be less than 10%. If a patient had at
least one embryo with the above criteria, she would be
included in the group with high-quality embryos. If a
patient did not have any embryos with the above criteira,
she would be included in the group without high-quality
embryos. No more than three embryos were transferred
into the uterine cavity on day 3 of in vitro culture. Clinical
pregnancy was diagnosed when the gestational sac and
fetal heart beat were observed under ultrasound 5 weeks
after embryo transfer.n between GDF9 and BMP15 expression and oocyte
bers on the horizontal axes refer to the oocyte maturation rate (MII),
itudinal axes refer to the relative mRNA expression of GDF9 or BMP15.
sion of GDF9 mRNA. (b) The correlation between normal fertilization
n cleavage rate and the relative expression of GDF9 mRNA. (d) The
BMP15 mRNA. (e) The correlation between normal fertilization rate and
ge rate and the relative expression of BMP15 mRNA.
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The one-sample Kolmogorov-Smirnov test was used to
examine the normal distribution of all data. The relative
expression levels of GDF9 and BMP15 mRNAs were
logarithmically transformed into a normal distribution.
The data in the tables were expressed as means ± stand-
ard deviation (SD). Pearson correlation analysis was used
to analyze the correlation between OSF expression and
general physiological paratmeters. Partial correlation
analysis was used to analyze the correlation between
GDF9 and BMP15 expression and oocyte developmental
potential after age adjustment. Covariance analysis was
used to compare GDF9 and BMP15 expression in differ-
ent groups after adjusting for the number of retrieved
oocytes. Receiver operating characteristic (ROC) curves
were used to examine the diagnostic value of GDF9 and
BMP15 mRNA for predicting pregnancy. The area under
the curve (AUC) represents the probability of correctly
identifying the pregnant and nonpregnant cases. Data
analysis was conducted with SPSS 11.5, and P < 0.05 was
considered as statistically significant.
Results
Correlation between the expression of GDF9 and BMP15
mRNAs and physiological parameters
The expression level of GDF9 mRNA was significantly
associated with age and BMI but not FSH, and the coeffi-
cients of correlation were 0.278 (P < 0.05), 0.188 (P < 0.05),Table 2 Clinical parameters of the subjects with and without
Variable High-quality embryos
Cases 106
Age (years) 31.58 ± 4.91
BMI (kg/m2) 21.35 ± 2.63
Antral follicle count (both ovaries) 15.28 ± 6.25
Ovary volume (mL) 5.92 ± 2.46
FSH (IU/L) 8.24 ± 2.45
LH (IU/L) 5.30 ± 3.18
E2 (pg/mL) 50.81 ± 24.95
T (ng/L) 1.34 ± 0.60
PRL (pg/mL) 17.27 ± 11.90
Sperm number (×106/ml) 0.52 ± 0.12
Sperm motility (%) 2.82 ± 0.83
Days of stimulation 11.20 ± 2.87
Gonadotropin dose (IU) 2149.38 ± 893.95
Retrieved oocytes* 14.39 ± 4.49
Oocyte maturation rate (%) 85.06 ± 16.66
Normal fertilization rate (%)* 75.09 ± 17.42
Cleavage rate (%)* 91.67 ± 10.35
Pregnancy rate (%)* 58.49
*P < 0.05, the group with high-quality embryos compared with the group without hand 0.017 (P > 0.05), respectively (Figure 1a–c). Similarly,
the expression level of BMP15 mRNA was also associated
with age and BMI but not FSH, and the coefficients of
correlation were 0.324 (P < 0.05), 0.226 (P < 0.05), and
0.024 (P > 0.05), respectively (Figure 1d–f ).
Correlation between the expression of GDF9 and BMP15
mRNAs and oocyte developmental potential
The expression level of GDF9 mRNA was significantly
associated with oocyte maturation, normal fertilization, and
cleavage rate after age adjustment; and the partial correl-
ation coefficients were 0.353 (P < 0.001), 0.489 (P < 0.001),
and 0.592 (P < 0.001), respectively (Figure 2a–c). Similarly,
the expression level of BMP15 mRNA was also associated
with oocyte maturation, normal fertilization, and cleavage
rate after age adjustment; and the partial correlation coeffi-
cients were 0.345 (P < 0.001), 0.402 (P < 0.001), and 0.593
(P < 0.001), respectively (Figure 2d–f).
Comparison of the expression levels of GDF9 and
BMP15 mRNAs between the groups with and without
high-quality embryos
The patient information is presented in Table 2. The
relative expression levels of GDF9 and BMP15 mRNAs
in the group with high-quality embryos were 4.79 ± 0.27
and 3.21 ± 0.30, respectively, while their levels in the
group without high-quality embryos were 2.52 ± 0.39 and
1.69 ± 0.39, respectively. Thus, the expression levels ofhigh-quality embryos
No high-quality embryos P
90 -
32.29 ± 5.15 ns
21.75 ± 3.00 ns
12.28 ± 6.76 ns
5.57 ± 3.44 ns
9.56 ± 5.72 ns
5.11 ± 3.34 ns
62.48 ± 26.68 ns
2.19 ± 0.76 ns
15.82 ± 7.07 ns
0.49 ± 0.15 ns
3.56 ± 1.82 ns
10.42 ± 3.94 ns
2167.46 ± 1112.80 ns
9.79 ± 3.75 <0.01
82.26 ± 18.47 ns
65.29 ± 29.80 <0.01
81.02 ± 29.21 <0.01
42.22 <0.01
igh-quality embryos; ns: not significant.
Table 3 Clinical parameters of the subjects with and
without pregnancy
Variable Pregnancy Nonpregnancy P
Cases 100 96 -
Age (years) 30.74 ± 4.42 31.08 ± 5.16 ns
BMI (kg/m2) 21.19 ± 3.60 21.68 ± 2.76 ns
Antral follicle count
(both ovaries)
15.63 ± 6.23 11.94 ± 6.74 ns
Ovary volume (mL) 6.12 ± 3.18 5.34 ± 2.74 ns
FSH (IU/L) 8.30 ± 2.41 9.38 ± 5.63 ns
LH (IU/L) 5.19 ± 3.16 5.19 ± 3.39 ns
E2 (pg/mL) * 48.33 ± 37.49 64.46 ± 37.95 <0.01
T (ng/L) 1.73 ± 0.92 1.74 ± 0.79 ns
PRL (pg/mL) 15.91 ± 7.71 17.36 ± 8.97 ns
Sperm number (×106/ml) 0.35 ± 0.16 0.42 ± 0.18 ns
Sperm motility (%) 2.65 ± 0.63 2.85 ± 0.79 ns
Days of stimulation* 11.41 ± 2.33 10.24 ± 4.19 0.016
Gonadotropin dose (IU) 2212.09 ± 848.13 2089.00 ± 1127.21 ns
Retrieved oocytes* 14.14 ± 4.13 10.38 ± 3.31 <0.01
Oocyte maturation rate (%) 84.30 ± 13.67 83.38 ± 20.78 ns
Normal fertilization rate (%) 71.47 ± 17.93 69.63 ± 29.89 ns
Cleavage rate (%)* 90.05 ± 13.30 83.04 ± 27.96 0.024
*p < 0.05, the pregnancy group compared with the nonpregnancy group; ns:
not significant.
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F = 2.75) in the group with high-quality embryos were
signifcantly greater than those in the group without
high-quality embryos after adjusting for the number of
retrieved oocytes (Figure 3a–b).
Comparison of the expression levels of GDF9 and BMP15
mRNAs between the groups with or without pregnancy
The patient information is presented in Table 3. The
expression level of GDF9 mRNA in the pregnancy group
(4.40 ± 1.55) was significantly greater than that in the
nonpregnancy group (2.65 ± 0.24) (P < 0.05, F = 18.35,
Figure 4a). Also, the BMP15 mRNA level in the preg-
nancy group (2.79 ± 0.17) was significantly greater than
that in the nonpregnancy group (1.93 ± 0.25) after
adjusting for the number of retrieved oocytes (P < 0.05,
F = 1.96, Figure 4b).
Diagnostic value of GDF9 and BMP15 mRNAs for
predicting pregnancy
The diagnostic value of GDF9 and BMP15 mRNAs for
predicting pregnancy is summarized in Table 4. The area
under the ROC curve of GDF9 mRNA for predicting
pregnancy was 0.816 (0.757–0.875), with a cut-off value
of 4.82, a sensitivity of 82%, and a specificity of 64%. The
area under the ROC curve of BMP15 for predicting
pregnancy was 0.746 (0.671–0.821), with a cut-off value
of 2.60, a sensitivity of 78%, and a specificity of 52%.
Discussion
In the present study, a qPCR method was used to detect
the expression levels of GDF9 and BMP15 mRNAs in
cumulus granulosa cells from patients who underwent
ICSI. The correlation between GDF9 or BMP15 mRNA
and oocyte development potential was analyzed in order
to explore new biomarkers for embryo selection.Figure 3 Comparison of OSFs mRNA levels between the groups with an
mRNA (a) in the groups with high-quality embryos. (b) The relative expressioOSFs are not only autocrine but also paracrine factors.
GDF9 and BMP15 were examined to predict oocyte de-
velopmental potential, while previous studies have only
detected the expression levels of some downstream
genes [22,23]. Many studies have confirmed that both
GDF9 and BMP15 are expressed in the oocyte cytoplasm
and cumulus granulosa cells [19-21]. In animal studies,
it has been shown that GDF9 and BMP15 can stimulated without high-quality embryo. The relative expression of GDF9
n of BMP15 mRNA in the groups without high-quality embryos. *P<0.05.
Figure 4 Comparison of OSFs mRNA levels between the groups with and without pregnancy. (a) The relative expression of GDF9 mRNA in
the pregnancy group and the nonpregnancy group. (b) The relative expression of BMP15 mRNA in the pregnancy group and the nonpregnancy
group. *P<0.05.
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matured with exogenous GDF9 had a higher percentage
of hatching blastocysts and a better blastocyst quality,
and the number of viable fetuses was also increased [25].
GDF9 and BMP15 play an important role in oocyte
development. Both factors contribute to promoting the
proliferation and metabolism of granulosa cells, and
stimulate the expression of kit ligand (KL) on granulosa
cells. The KL acts on its receptor on the oocyte and
modulates oocyte development [26]. To date, the expres-
sion of GDF9 and BMP15 mRNAs has not been used to
predict oocyte quality. Here, we found that the expres-
sion of GDF9 and BMP15 mRNAs in cumulus granulosa
cells was positively correlated with oocyte maturation,
normal fertilization rate, and cleavage rate. Because
cumulus granulosa cells are closely associated with the
oocyte, the expression of GDF9 and BMP15 mRNA in
cumulus granulosa cells may reflect oocyte develop-
mental potential.
In addition, we observed that the mRNA expression of
GDF9 and BMP15 were positively associated with age
and BMI. Age and BMI are important factors that may
affect the ovarian response and pregancy outcome of
assisted reproductive technology. However, the age and
BMI may not have a direct relationship with the expres-
sion of GDF9 and BMP15; therefore, further investigation
is needed. Furthermore, the rate of oocyte maturation in
the group with higher expression of GDF9 and BMP15
mRNA was significantly greater than that in the groupTable 4 Diagnostic values of GDF9 and BMP15 for predicting
OSFs AUC P value
GDF9 0.816 (0.757–0.875) <0.001
BMP15 0.746 (0.671–0.821) <0.001with lower GDF9 and BMP15 mRNA expression. The rate
of oocyte maturation was positively related to the mRNA
expression of GDF9 and BMP15. Fertilization is closely
related to oocyte quality such as oocyte maturation and
spindle structure [27-30]. The fertilization rate in high-
quality oocytes is often greater than that in low-quality
oocytes. Low-quality oocytes tend to have a higher ab-
normal fertilization rate due to imperfect oocyte func-
tion. Our results indicated that the fertilization rate
increased along with the increased mRNA levels of
GDF9 and BMP15. Moreover, oocyte quality dramatically
affects subsequent embryo development. Low-quality
oocytes often have a lower chance of developing into
high-quality embryos [31]. Accordingly, the patients with
a higher expression of OSFs also had a higher cleavage
rate. This evidence helps to explain our findings that the
expression of GDF9 and BMP15 mRNAs in the group
with high quality embryos was significantly greater than
that in the group without a high quality embryo. Clinical
pregnancy is an important indicator for evaluating embryo
quality. Although the pregnancy outcome is determined
by several factors such as sperm quality and the uterine
endometrium, the oocyte is the most important factor
for clinical outcome. A high-quality oocyte more easily
develops into a high-quality embryo; accordingly, the
chance of clinical pregnancy is also increased [32]. The
present study confirmed that the expression of GDF9 and
BMP15 mRNAs in the pregnancy group was significantly
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be used as an indicator to predict clinical pregnancy
outcome. As the ROC curve was used to evaluate the
diagnostic value of GDF9 and BMP15 mRNAs, the cut-
off value can be established for predicting pregnancy
with a relatively high sensitivity. These data indicate
that the detection of GDF9 and BMP15 mRNAs in cumu-
lus granulosa cells may have broad application prospects
as invasive biomarkers for evaluating ooctye develop-
mental potential.
However, the limitation of this study is that the cumulus
granulosa cells were not harvested from an individual
oocyte, so the expression of GDF9 and BMP15 mRNA
does not match with each oocyte and embryo. A future
study that detects the expression of OSFs from an indi-
vidual follicle is still needed to validate the conclusion.
Additionally, there may be some other OSFs such as
BMP6 and fibroblast growth factor (FGF) 8B that could
be used as biomarkers [33,34]. In the present study, we
only detected the mRNA expression of the two well-known
factors GDF9 and BMP15 in cumulus granulosa cells. It
will be interesting to explore the relationship between
the mRNA expression of other OSFs and oocyte devel-
opmental potential in the future.
Conclusions
The expression of GDF9 and BMP15 mRNAs was sig-
nificantly correlated with oocyte maturation, fertilization,
embryo quality, and clinical pregnancy outcome. Thus,
the levels of GDF9 and BMP15 mRNA in cumulus
granulosa cells may be considered as new biomarkers
for predicting oocyte developmental potential.
Abbreviations
E2: Estradiol; FSH: Follicle-stimulating hormone; LH: Luteinizing hormone;
PRL: Prolactin; T: Testosterone.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YL collected the data and drafted the manuscript. R-QL, S-BO, and N-FZ
performed the qRT-PCR. LR, Q-XZ, and D-ZY revised the manuscript. L-NW
designed the study and validated the data. All authors read and approved
the final manuscript.
Acknowledgments
This work was supported by grants from the National Science Fund of China
(Nos. 81200417 and 81200476), the Doctoral Fund of the Ministry of Education
of China (Nos. 20120171120093 and 20120171120122), the Science Fund of
Guangdong Province (S2012040007621 and S2012040007770), the Medical
Research Fund of Guangdong Province (B2012104 and B2012150), the Young
Teacher Fund of Sun Yat-sen University (11ykpy24), the Project of Science and
Technology New Star in Zhu Jiang of Guangzhou City (2014 J2200044), and the
Yat-Sen Scholarship for Young Scientists. We thank the editors from Medjaden
Bioscience Limited for proofreading the manuscript.
Author details
1Reproductive Medicine Research Center, Memorial Hospital of Sun Yat-Sen
University, 107 Yan-jiang-xi Road, Guangzhou 510120, China. 2Ultrasound
Diagnostic Center, First Affiliated Hospital of Gannan Medical Collage, 23Qing-nian Road, Gangzhou 341000, China. 3Reproductive Medicine Research
Center, Sixth Affiliated Hospital of Sun Yat-Sen University, 17 Shou-gou-ling
Road, Guangzhou 510655, China.
Received: 4 April 2014 Accepted: 26 July 2014
Published: 20 August 2014References
1. Scott L, Smith S: The successful use of pronuclear embryo transfers the
day following oocyte retrieval. Hum Reprod 1998, 13:1003–1013.
2. Dennis SJ, Thomas MA, Williams DB, Robins JC: Embryo morphology score
on day 3 is predictive of implantation and live birth rates. J Assist Reprod
Genet 2006, 23:171–175.
3. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB: Blastocyst
score affects implantation and pregnancy outcome: towards a single
blastocyst transfer. Fertil Steril 2000, 73:1155–1158.
4. Wang Q, Sun QY: Evaluation of oocyte quality: morphological, cellular
and molecular predictors. Reprod Fertil Dev 2007, 19:1–12.
5. Seli E, Robert C, Sirard MA: OMICS in assisted reproduction: possibilities
and pitfalls. Mol Hum Reprod 2010, 16:513–530.
6. Gilchrist RB, Ritter LJ, Armstrong DT: Oocyte-somatic cell interactions during
follicle development in mammals. Anim Reprod Sci 2004, 82–83:431–446.
7. Kidder GM, Vanderhyden BC: Bidirectional communication between
oocytes and follicle cells: ensuring oocyte developmental competence.
Can J Physiol Pharmacol 2010, 88:399–413.
8. Canipari R: Oocyte–granulosa cell interactions. Hum Reprod Update 2000,
6:279–289. Review.
9. Cillo F, Brevini TA, Antonini S, Paffoni A, Ragni G, Gandolfi F: Association
between human oocyte developmental competence and expression
levels of some cumulus genes. Reproduction 2007, 134:645–650.
10. Anderson RA, Sciorio R, Kinnell H, Bayne RA, Thong KJ, de Sousa PA,
Pickering S: Cumulus gene expression as a predictor of human oocyte
fertilisation, embryo development and competence to establish a
pregnancy. Reproduction 2009, 138:629–637.
11. Paulini F, Melo EO: The role of oocyte-secreted factors GDF9 and BMP15
in follicular development and oogenesis. Reprod Domest Anim 2011,
46:354–361.
12. Trombly DJ, Woodruff TK, Mayo KE: Roles for transforming growth factor
beta superfamily proteins in early folliculogenesis. Semin Reprod Med
2009, 27:14–23.
13. Kedem A, Fisch B, Garor R, Ben-Zaken A, Gizunterman T, Felz C, Ben-Haroush A,
Kravarusic D, Abir R: Growth differentiating factor 9 (GDF9) and bone
morphogenetic protein 15 both activate development of human
primordial follicles in vitro, with seemingly more beneficial effects of
GDF9. J Clin Endocrinol Metab 2011, 96:1246–1254.
14. McNatty KP, Hudson NL, Whiting L, Reader KL, Lun S, Western A, Heath DA,
Smith P, Moore LG, Juengel JL: The effects of immunizing sheep with
different BMP15 or GDF9 peptide sequences on ovarian follicular activity
and ovulation rate. Biol Reprod 2007, 76:552–560.
15. Gode F, Gulekli B, Dogan E, Korhan P, Dogan S, Bige O, Cimrin D, Atabey N:
Influence of follicular fluid GDF9 and BMP15 on embryo quality. Fertil
Steril 2011, 95:2274–2278.
16. Wu YT, Tang L, Cai J, Lu XE, Xu J, Zhu XM, Luo Q, Huang HF: High
bonemorphogenetic protein-15 level in follicular fluid is associated
with high quality oocyte and subsequent embryonic development.
Hum Reprod 2007, 22:1526–1531.
17. Sudiman J, Ritter LJ, Feil DK, Wang X, Chan K, Mottershead DG, Robertson DM,
Thompson JG, Gilchrist RB: Effects of differing oocyte-secreted factors during
mouse in vitro maturation on subsequent embryo and fetal development.
J Assist Reprod Genet 2014, 31:295–306.
18. Lin ZL, Li YH, Xu YN, Wang QL, Namgoong S, Cui XS, Kim NH: Effects of
growth differentiation factor 9 and bone morphogenetic protein 15 on
the in vitro maturation of porcine oocytes. Reprod Domest Anim 2014,
49:219–227.
19. Zhao SY, Qiao J, Chen YJ, Liu P, Li J, Yan J: Expression of growth
differentiation factor-9 and bone morphogenetic protein-15 in oocytes
and cumulus granulosa cells of patients with polycystic ovary syndrome.
Fertil Steril 2010, 94:261–267.
20. Hosoe M, Kaneyama K, Ushizawa K, Hayashi KG, Takahashi T: Quantitative
analysis of bone morphogenetic protein 15 (BMP15) and growth
Li et al. Reproductive Biology and Endocrinology 2014, 12:81 Page 9 of 9
http://www.rbej.com/content/12/1/81differentiation factor 9 (GDF9) gene expression in calf and adult bovine
ovaries. Reprod Biol Endocrinol 2011, 9:33.
21. Silva JR, van den Hurk R, van Tol HT, Roelen BA, Figueiredo JR: Expression
of growth differentiation factor 9 (GDF9), bone morphogenetic protein
15 (BMP15), and BMP receptors in the ovaries of goats. Mol Reprod Dev
2005, 70:11–19.
22. Adriaenssens T, Wathlet S, Segers I, Verheyen G, De Vos A, Van der Elst J,
Coucke W, Devroey P, Smitz J: Cumulus cell gene expression is associated
with oocyte developmental quality and influenced by patient and
treatment characteristics. Hum Reprod 2010, 25:1259–1270.
23. McKenzie LJ, Pangas SA, Carson SA, Kovanci E, Cisneros P, Buster JE, Amato P,
Matzuk MM: Human cumulus granulosa cell gene expression: a predictor of
fertilization and embryo selection in women undergoing IVF. Hum Reprod
2004, 19:2869–2874.
24. Sudiman J, Ritter LJ, Feil DK, Wang X, Chan K, Mottershead DG, Robertson DM,
Thompson JG, Gilchrist RB: Effects of differing oocyte-secreted factors during
mouse in vitro maturation on subsequent embryo and fetal development.
J Assist Reprod Genet 2014, 31:295–306.
25. Lin ZL, Li YH, Xu YN, Wang QL, Namgoong S, Cui XS, Kim NH: Effects of
growth differentiation factor 9 and bone morphogenetic protein 15 on
the in vitro maturation of porcine oocytes. Reprod Domest Anim 2014,
49:219–227.
26. Gilchrist RB, Lane M, Thompson JG: Oocyte-secreted factors: regulators of
cumulus cell function and oocyte quality. Hum Reprod Update 2008,
14:159–177.
27. Bilodeau-Goeseels S, Panich P: Effects of oocyte quality on development
and transcriptional activity in early bovine embryos. Anim Reprod Sci
2002, 71:143–155.
28. Wang W, Hosoe M, Li R, Shioya Y: Development of the competence of
bovine oocytes to release cortical granules and block polyspermy after
meiotic maturation. Dev Growth Differ 1997, 39:607–615.
29. Santos P, Chaveiro A, Simões N, Moreira da Silva F: Bovine oocyte quality
in relation to ultrastructural characteristics of zona pellucida,
polyspermic penetration and developmental competence. Reprod Domest
Anim 2008, 43:685–689.
30. Watson AJ: Oocyte cytoplasmic maturation: a key mediator of oocyte
and embryo developmental competence. J Anim Sci 2007, 85:1–3.
31. Hill GA, Freeman M, Bastias MC, Rogers BJ, Herbert CM 3rd, Osteen KG,
Wentz AC: The influence of oocyte maturity and embryo quality on
pregnancy rate in a program for in vitro fertilization-embryo transfer.
Fertil Steril 1989, 52:801–806.
32. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C: Effect of embryo
quality on pregnancy outcome following single embryo transfer in women
with a diminished egg reserve. Fertil Steril 2007, 87:749–756.
33. Juengel JL, McNatty KP: The role of proteins of the transforming
growthfactor-beta superfamily in the intraovarian regulation of follicular
development. Hum Reprod Update 2005, 11:143–160.
34. Sugiura K, Su YQ, Diaz FJ, Pangas SA, Sharma S, Wigglesworth K, O'Brien MJ,
Matzuk MM, Shimasaki S, Eppig JJ: Oocyte-derived BMP15 and FGFs
cooperate to promote glycolysis in cumulus cells. Development 2007,
134:2593–2603.
doi:10.1186/1477-7827-12-81
Cite this article as: Li et al.: Increased GDF9 and BMP15 mRNA levels in
cumulus granulosa cells correlate with oocyte maturation, fertilization,
and embryo quality in humans. Reproductive Biology and Endocrinology
2014 12:81.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
